Atlas Trials

Treatment of COVID-19 Post-acute Cognitive Impairment Sequelae With tDCS

Clinical trial NCT05389592 · COMPLETED

Trial details

NCT number
NCT05389592
Sponsor
University of Sao Paulo
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Cognitive ImpairmentPost-Acute Sequelae of SARS-CoV-2 InfectionCOVID-19
Start date
2022-06-30
Primary completion
2022-11-30
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.